Kongressthemen We present the Neuroimmunology Drug Development Summit, the industry's definitive and unrivalled forum focused on pushing the frontiers of targeting neuroinflammation for CNS Indications.
As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics.
Kongressorganizer (PCO) Hanson Wade
Anmerkungen Speakers: Andrea Crotti, Principal Scientist - Early Target Discovery, Takeda, Brad Friedman, Senior Scientist, Department of OMNI Bioinformatics, Genentech, Carlos Pedraza, Associate Director Neuroimmunology and MS Therapeutics, Sanofi, and more.
